President Biden’s renewed push to develop cures for society’s most devastating diseases including cancer and Alzheimer’s, in tandem with infrastructure investments to “Build Back Better,” represents an opportunity to harness our nation’s critical shared research resources (SRRs). For over 40 years, SRRs have played a key role in accelerating biomedical research discoveries and innovations by providing widespread access to cutting-edge technologies, services, and scientific expertise. Yet a national strategy that addresses how to leverage these resources to ensure new treatments, cures, and economic vitality is noticeably absent. A national strategy for SRRs—led by the National Institutes of Health (NIH)—is crucial to advance key national initiatives and enable long-term efficiency, coordination, and economic impact of these critical assets.
Establishing a national strategy for shared research resources in biomedical sciences
